Search Results - "Lenting, Peter J"
-
1
Emicizumab and thrombosis: The story so far
Published in Journal of thrombosis and haemostasis (01-08-2019)Get full text
Journal Article -
2
von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends
Published in Blood (26-03-2015)“…To understand the placement of a certain protein in a physiological system and the pathogenesis of related disorders, it is not only of interest to determine…”
Get full text
Journal Article -
3
Laboratory monitoring of hemophilia A treatments: new challenges
Published in Blood advances (12-05-2020)“…Monitoring factor VIII (FVIII) activity has traditionally been complicated by discrepancies between assays for the various sorts of FVIII molecules. The advent…”
Get full text
Journal Article -
4
Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
Published in Nature communications (29-07-2020)“…Targeted genome editing has a great therapeutic potential to treat disorders that require protein replacement therapy. To develop a platform independent of…”
Get full text
Journal Article -
5
Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support
Published in Journal of the American College of Cardiology (15-05-2018)“…The main risk factor for bleeding in patients with continuous-flow mechanical circulatory support (CF-MCS) is the acquired von Willebrand factor (VWF) defect…”
Get full text
Journal Article -
6
Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant
Published in Blood (25-04-2013)“…Recombinant adeno-associated virus (rAAV) vectors encoding human factor VIII (hFVIII) were systematically evaluated for hemophilia A (HA) gene therapy. A…”
Get full text
Journal Article -
7
How to keep the factor VIII/von Willebrand factor complex in the circulation
Published in Haematologica (Roma) (25-11-2021)Get full text
Journal Article -
8
Differences in venous clot structures between hemophilic mice treated with emicizumab versus factor VIII or factor VIIIFc
Published in Haematologica (Roma) (01-06-2024)“…Recombinant factor VIII (rFVIII), rFVIIIFc and emicizumab are established treatment options in the management of hemophilia A. Each has its unique mode of…”
Get full text
Journal Article -
9
The von Willebrand Factor A1 domain mediates thromboinflammation, aggravating ischemic stroke outcome in mice
Published in Haematologica (Roma) (01-03-2021)“…von Willebrand factor (VWF) plays an important role in ischemic stroke. However, the exact mechanism by which VWF mediates progression of ischemic stroke brain…”
Get full text
Journal Article -
10
Macrophage scavenger receptor SR-AI contributes to the clearance of von Willebrand factor
Published in Haematologica (Roma) (01-04-2018)“…Previously, we found that LDL-receptor related protein-1 on macrophages mediated shear stress-dependent clearance of von Willebrand factor. In control…”
Get full text
Journal Article -
11
Non-inhibitory antibodies inducing increased emicizumab clearance in a severe haemophilia A inhibitor patient
Published in Haematologica (Roma) (20-05-2021)“…Authorship Contributions: AH, CB were in charge of the patients and provided the clinical samples. MD, DB and DL performed the coagulation tests. TS, CC, IP…”
Get full text
Journal Article -
12
Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA
Published in Haematologica (Roma) (01-04-2020)“…The treatment or prevention of bleeding in patients with hemophilia A relies on replacement therapy with different factor VIII (FVIII)-containing products or…”
Get full text
Journal Article -
13
Author Correction: Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
Published in Nature communications (13-08-2020)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
14
von Willebrand Factor as a Biological Sensor of Blood Flow to Monitor Percutaneous Aortic Valve Interventions
Published in Circulation research (27-03-2015)“…RATIONALE:Percutaneous aortic valve procedures are a major breakthrough in the management of patients with aortic stenosis. Residual gradient and residual…”
Get full text
Journal Article -
15
Macrophage LRP1 contributes to the clearance of von Willebrand factor
Published in Blood (01-03-2012)“…The relationship between low-density lipoprotein receptor–related protein-1 (LRP1) and von Willebrand factor (VWF) has remained elusive for years. Indeed,…”
Get full text
Journal Article -
16
PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space
Published in CPT: pharmacometrics and systems pharmacology (01-10-2024)“…Patients with severe and sometimes moderate hemophilia B are prophylactically treated with factor IX concentrates to prevent bleeding. For some time now,…”
Get full text
Journal Article -
17
Accelerated uptake of VWF/platelet complexes in macrophages contributes to VWD type 2B–associated thrombocytopenia
Published in Blood (17-10-2013)“…Von Willebrand disease (VWD) type 2B is characterized by mutations causing enhanced binding of von Willebrand factor (VWF) to platelets. Bleeding tendency is…”
Get full text
Journal Article -
18
Transient von Willebrand factor‐mediated platelet influx stimulates liver regeneration after partial hepatectomy in mice
Published in Liver international (01-11-2017)“…Background & Aims In addition to their function in thrombosis and haemostasis, platelets play an important role in the stimulation of liver regeneration. It…”
Get full text
Journal Article -
19
Monoclonal gammopathy of clinical significance: in vivo demonstration of the anti-thrombotic effect of an acquired anti-thrombin antibody
Published in Haematologica (Roma) (01-01-2021)Get full text
Journal Article -
20
Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1
Published in The Journal of experimental medicine (12-06-2006)“…Collagens are the most abundant proteins in the human body, important in maintenance of tissue structure and hemostasis. Here we report that collagens are high…”
Get full text
Journal Article